Objective: To compare two oral extended-release (ER) carbidopa-levodopa (CD-LD) formulations, CREXONT® and RYTARY®
Contact Us: hello@amdapp.org
A nonprofit 501c3 membership organization EIN 92-0662557
© 2024 AMDAPP
Add us to your inbox!
We hate spam, and we respect your privacy!
Add us to your inbox!
We hate spam, and we respect your privacy!